Warning: The NCBI web site requires JavaScript to function. more...
Fetching bibliography...
Generate a file for use with external citation management software.
Grepafloxacin: microbiological properties.
Marriott MS.
Clin Microbiol Infect. 1998 Mar;4 Suppl 1:S9-S14.
Similar articles
Sordarins: in vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii, and filamentous fungi.
Herreros E, Martinez CM, Almela MJ, Marriott MS, De Las Heras FG, Gargallo-Viola D.
Antimicrob Agents Chemother. 1998 Nov;42(11):2863-9.
Sordarins: A new class of antifungals with selective inhibition of the protein synthesis elongation cycle in yeasts.
Domínguez JM, Kelly VA, Kinsman OS, Marriott MS, Gómez de las Heras F, Martín JJ.
Antimicrob Agents Chemother. 1998 Sep;42(9):2274-8.
The dog did nothing in the night-time.
Nature. 1997 May 8;387(6629):119. No abstract available.
TEM- and SHV-derived extended-spectrum beta-lactamases: relationship between selection, structure and function.
Du Bois SK, Marriott MS, Amyes SG.
J Antimicrob Chemother. 1995 Jan;35(1):7-22. Review.
Protein O-mannosylation in Candida albicans. Determination of the amino acid sequences of peptide acceptors for protein O-mannosyltransferase.
Weston A, Nassau PM, Henly C, Marriott MS.
Eur J Biochem. 1993 Aug 1;215(3):845-9.
Plasmid mediated ceftazidime resistance identified in a strain of Serratia marcescens isolated in Belgium.
Payne DJ, Marriott MS, Amyes SG.
J Antimicrob Chemother. 1991 May;27(5):689-93. No abstract available.
No detection of characteristic fungal protein elongation factor EF-3 in Pneumocystis carinii.
Jackson HC, Colthurst D, Hancock V, Marriott MS, Tuite MF.
J Infect Dis. 1991 Mar;163(3):675-7.
Separation of plasmid-mediated extended spectrum beta-lactamases by fast protein liquid chromatography (FPLC system).
Payne DJ, Hood J, Marriott MS, Amyes SG.
FEMS Microbiol Lett. 1990 Jun 1;57(3):195-200.
Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
J Med Microbiol. 1990 Jun;32(2):131-4.
Discovery of fluconazole, a novel antifungal agent.
Richardson K, Cooper K, Marriott MS, Tarbit MH, Troke PF, Whittle PJ.
Rev Infect Dis. 1990 Mar-Apr;12 Suppl 3:S267-71. Review.
Mutants of the TEM-1 beta-lactamase conferring resistance to ceftazidime.
J Antimicrob Chemother. 1989 Aug;24(2):103-10.
TEM-E1: a novel beta-lactamase conferring resistance to ceftazidime.
FEMS Microbiol Lett. 1989 May;50(1-2):97-100.
1-(3-cyano-2,3-dideoxy-beta-D-erythro-pentofuranosyl)thymine (cyanothymidine): synthesis and antiviral evaluation against human immunodeficiency virus.
Greengrass CW, Hoople DW, Street SD, Hamilton F, Marriott MS, Bordner J, Dalgleish AG, Mitsuya H, Broder S.
J Med Chem. 1989 Mar;32(3):618-22.
In vitro potency and in vivo activity of azoles.
Troke PF, Marriott MS, Richardson K, Tarbit MH.
Ann N Y Acad Sci. 1988;544:284-93. No abstract available.
Design and evaluation of a systemically active agent, fluconazole.
Ann N Y Acad Sci. 1988;544:4-11. No abstract available.
Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.
Troke PF, Andrews RJ, Marriott MS, Richardson K.
J Antimicrob Chemother. 1987 May;19(5):663-70.
An alteration in tubulin expression detected in SV40 transformed 3T3 cells.
Raxworthy MJ, Shaw JR, Marriott MS.
Cell Biol Int Rep. 1986 Jul;10(7):555-63.
Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.
Troke PF, Andrews RJ, Brammer KW, Marriott MS, Richardson K.
Antimicrob Agents Chemother. 1985 Dec;28(6):815-8.
Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes.
Richardson K, Brammer KW, Marriott MS, Troke PF.
Antimicrob Agents Chemother. 1985 May;27(5):832-5.
Tioconazole, a new imidazole-antifungal agent for the treatment of dermatomycoses. Antifungal and pharmacologic properties.
Marriott MS, Baird JR, Brammer KW, Faulkner JK, Halliwell G, Jevons S, Tarbit MH.
Dermatologica. 1983;166 Suppl 1:1-7.
Tioconazole, a new broad-spectrum antifungal agent: preclinical studies related to vaginal candidiasis.
Marriott MS, Brammer KW, Faccini J, Faulkner JK, Jevons S, Monro AM, Nachbaur J, Perraud J, Tarbit MH.
Gynakol Rundsch. 1983;23 Suppl 1:1-11. No abstract available.
Inhibition of sterol C14 demethylation by imidazole-containing antifungals.
Pye GW, Marriott MS.
Sabouraudia. 1982 Dec;20(4):325-9. No abstract available.
Inhibition of sterol biosynthesis in Candida albicans by imidazole-containing antifungals.
J Gen Microbiol. 1980 Mar;117(1):253-5.
Mannan-protein location and biosynthesis in plasma membranes from the yeast form of Candida albicans.
J Gen Microbiol. 1977 Nov;103(1):51-9. No abstract available.
Growth characteristics and polyene sensitivity of a fatty acid auxotroph of Candida albicans.
Koh TY, Marriott MS, Taylor J, Gale EF.
J Gen Microbiol. 1977 Sep;102(1):105-10.
Enzymic activity of purified plasma membranes from the yeast and mycelial forms of Candida albicans.
J Gen Microbiol. 1975 Aug;89(2):345-52.
Isolation and chemical characterization of plasma membranes from the yeast and mycelial forms of Candida albicans.
J Gen Microbiol. 1975 Jan;86(1):115-32.
Filters: Manage Filters